BATM Advanced Communications Ltd.

Tel Aviv Stock Exchange BVC.TA

BATM Advanced Communications Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 120.34 M

BATM Advanced Communications Ltd. Shareholders' Equity is USD 120.34 M for the year ending December 31, 2023, a 4.59% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • BATM Advanced Communications Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 115.07 M, a -9.70% change year over year.
  • BATM Advanced Communications Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 127.42 M, a 3.94% change year over year.
  • BATM Advanced Communications Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 122.59 M, a 12.65% change year over year.
  • BATM Advanced Communications Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 108.82 M, a 24.55% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
Tel Aviv Stock Exchange: BVC.TA

BATM Advanced Communications Ltd.

CEO Mr. Moti Nagar CPA
IPO Date Feb. 27, 2019
Location Israel
Headquarters Neve Ne’eman Ind. Area
Employees 980
Sector Communication Services
Industries
Description

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email